• Home
  • NAMs & SVC
  • NeXST SVC
  • Cardiac safety+AI

Lung fibrosis

High-fidelity hiPSC-Cardiomyocytes
with AI-driven Modeling

NEXEL’s AI-based cardiotoxicity evaluation goes beyond the traditional qualitative assessment of arrhythmia risks –
It quantitatively evaluates cardiotoxicity risk through AI analysis trained on CiPA standard toxicant data
Beyond conventional boundaries,
we deliver a bold new paradigm.
  • iPSC technologyCONTACT

    Contact Information

    • Address: 8F, 55 Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea(07802)

    • Business Registration No.: 109-86-37282
    • CEO: Choongseong Han

    • Tel : +82-2-2088-8886
    • Fax: +82-2-2088-8884
    • E-mail : support@nexel.co.kr